Amedisys, Inc. (AMED)
Aug 14, 2025 - AMED was delisted (reason: acquired by UNH)
100.99
+0.01 (0.01%)
Inactive · Last trade price on Aug 14, 2025

Amedisys Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Cash & Equivalents
337.3303.24126.4540.5442.6981.81
Cash & Short-Term Investments
337.3303.24126.4540.5442.6981.81
Cash Growth
125.05%139.81%211.91%-5.04%-47.81%170.05%
Accounts Receivable
295.52296.08313.37296.79274.96255.15
Other Receivables
-10.214.812.412.12.5
Receivables
295.52306.28328.17309.19287.06257.65
Prepaid Expenses
18.2813.0714.6411.6310.3610.22
Restricted Cash
--12.4113.593.081.55
Other Current Assets
11.099.4915.2614.0213.510.77
Total Current Assets
662.2632.08496.94388.96356.68361.98
Property, Plant & Equipment
124.89123.61130.78118.88119.69117.16
Long-Term Investments
11769.866.160.553.114.2
Goodwill
1,2141,2141,2451,2871,196932.69
Other Intangible Assets
79.2481.16102.68101.17111.1974.18
Long-Term Deferred Tax Assets
----0.2947.99
Other Long-Term Assets
18.1718.181919.3419.9219
Total Assets
2,2152,1392,0601,9761,8571,567

Liabilities

Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Accounts Payable
29.7939.9628.2443.7438.2242.67
Accrued Expenses
393.09410.56375.78207.58229.04235.02
Current Portion of Long-Term Debt
36.822.4722.5114.312.18.8
Current Portion of Leases
26.8841.4140.0934.7232.1331.75
Current Unearned Revenue
-----11.6
Other Current Liabilities
1.8-7.155.262.8126.5
Total Current Liabilities
488.36514.39473.72355.53374.28456.34
Long-Term Debt
299.73325.31346.76418.32431.38203.61
Long-Term Leases
87.170.1177.8570.670.0162.89
Long-Term Deferred Tax Liabilities
64.4548.0540.6420.41--
Other Long-Term Liabilities
0.850.881.424.814.9833.62
Total Liabilities
940.48958.75940.39869.67880.65756.46

Shareholders' Equity

Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Common Stock
0.040.040.040.040.040.04
Additional Paid-In Capital
833.1818.2787.18755.06728.12698.29
Retained Earnings
880.25791.16747.93757.67639.06429.99
Treasury Stock
-480.86-474.85-468.63-461.2-435.87-319.09
Total Common Equity
1,2331,1351,0671,052931.35809.22
Minority Interest
42.3745.4253.275544.971.52
Shareholders' Equity
1,2751,1801,1201,107976.32810.74
Total Liabilities & Equity
2,2152,1392,0601,9761,8571,567

Additional Metrics

Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Total Debt
450.51459.3487.21537.94545.61307.04
Net Cash (Debt)
-113.2-156.06-360.76-497.4-502.92-225.23
Net Cash Growth
------
Net Cash Per Share
-3.41-4.72-11.07-15.23-15.25-6.77
Filing Date Shares Outstanding
32.8938.3732.6732.5532.5332.85
Total Common Shares Outstanding
32.8832.7832.6732.5232.5132.81
Working Capital
173.84117.6923.2133.43-17.6-94.35
Book Value Per Share
37.4834.6132.6532.3428.6524.66
Tangible Book Value
-60.6-160.5-280.84-336.99-375.93-197.64
Tangible Book Value Per Share
-1.84-4.90-8.60-10.36-11.56-6.02
Buildings
---9.79.19
Machinery
-78.6183.4556.9354.7453.12
Leasehold Improvements
-13.411---
SEC Filings: 10-K · 10-Q